Reporter brief
Quercetin and dasatinib associated with epigenetic aging measures over 16 weeks in healthy individuals
What happened
This observational study examined whether the senolytics quercetin and dasatinib affected epigenetic aging rates in healthy individuals over 16 weeks. Participants underwent epigenetic age testing at baseline, the 8-week midpoint, and after 16 weeks. The abstract does not report what effects were actually found.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Observational; Human.
Healthy individuals
- Design
- Observational
- Sample
- —
- Journal
- TruDiagnostic
- Published
- Aug 3, 2021
Effect size
Not recorded.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Senolytics timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.